Dr. Nobuto Yamamoto was born in Japan on April 25, 1925. Though accepted to three medical schools, he chose to focus on biochemistry in graduate school.
After graduation he served as associate professor at Gifu Medical School, Japan, until 1959.
Dr. Yamamoto worked as a visiting scientist in the Microbiology Group at the Institute for Cancer Research (Fox Cancer Center), Philadelphia, PA, from 1959 to 1961; his focus was on the genetic evolution of bacterial viruses.
In 1964 he joined the faculty at Temple University, Philadelphia, PA, as Head of Virology and Genetics of the Fels Cancer Research Institute until 1980.
In 1980 Dr. Yamamoto was appointed professor of Microbiology and Immunology at Hahnemann University School of Medicine, where he continued to study viral evolution. While at Hahnemann, he revived his graduate study of immunology from 35 years before and this led him to a deeper understanding of the mechanisms of macrophage activation and the subsequent discovery of GcMAF.
When Dr. Yamamoto retired from Hahnemann University in 1990, he was asked to return to Temple University Medical School as a Research Professor of Biochemistry. There he studied the tumoricidal capacity of macrophages activated by GcMAF, and cancer therapy with GcMAF.
In 1994 Dr. Yamamoto founded the Socrates Institute for Therapuetic Immunology in Philadelphia, where today, as institute director, he continues to study the therapeutic efficacy of GcMAF for a variety of cancers and HIV.
To make a donation supporting Dr. Yamamoto’s work, you can send a contribution to: Socrates Institute for Therapeutic Immunology, 1040 66th Ave., Philadelphia, PA 19126-3305.